Therefore, both clinical and research implications highlighted that LIGHT could represent a good pharmacological target to improve bone/fat homeostasis thus counteracting obesity and bone disease in PWS subjects. Here, TNFSF14 is linked to obesity due to melanocortin 4 receptor deficiency.